Back to Search
Start Over
Spatial and molecular mapping of Pfkelch13 gene polymorphism in Africa in the era of emerging Plasmodium falciparum resistance to artemisinin: a systematic review.
- Source :
-
The Lancet. Infectious diseases [Lancet Infect Dis] 2021 Apr; Vol. 21 (4), pp. e82-e92. Date of Electronic Publication: 2020 Oct 27. - Publication Year :
- 2021
-
Abstract
- The spread of Plasmodium falciparum isolates carrying mutations in the kelch13 (Pfkelch13) gene associated with artemisinin resistance (PfART-R) in southeast Asia threatens malaria control and elimination efforts. Emergence of PfART-R in Africa would result in a major public health problem. In this systematic review, we investigate the frequency and spatial distribution of Pfkelch13 mutants in Africa, including mutants linked to PfART-R in southeast Asia. Seven databases were searched (PubMed, Embase, Scopus, African Journal Online, African Index Medicus, Bioline, and Web of Science) for relevant articles about polymorphisms of the Pfkelch13 gene in Africa before January, 2019. Following PRISMA guidelines, 53 studies that sequenced the Pfkelch13 gene of 23 100 sample isolates in 41 sub-Saharan African countries were included. The Pfkelch13 sequence was highly polymorphic (292 alleles, including 255 in the Pfkelch13-propeller domain) but with mutations occurring at very low relative frequencies. Non-synonymous mutations were found in only 626 isolates (2·7%) from west, central, and east Africa. According to WHO, nine different mutations linked to PfART-R in southeast Asia (Phe446Ile, Cys469Tyr, Met476Ile, Arg515Lys, Ser522Cys, Pro553Leu, Val568Gly, Pro574Leu, and Ala675Val) were detected, mainly in east Africa. Several other Pfkelch13 mutations, such as those structurally similar to southeast Asia PfART-R mutations, were also identified, but their relevance for drug resistance is still unknown. This systematic review shows that Africa, thought to not have established PfART-R, reported resistance-related mutants in the past 5 years. Surveillance using PfART-R molecular markers can provide valuable decision-making information to sustain the effectiveness of artemisinin in Africa.<br /> (Copyright © 2021 Elsevier Ltd. All rights reserved.)
- Subjects :
- Africa epidemiology
Antimalarials pharmacology
Antimalarials therapeutic use
Artemisinins therapeutic use
DNA, Protozoan genetics
DNA, Protozoan isolation & purification
Genes, Protozoan genetics
Humans
Malaria, Falciparum epidemiology
Malaria, Falciparum parasitology
Mutation
Plasmodium falciparum drug effects
Plasmodium falciparum isolation & purification
Polymorphism, Single Nucleotide
Artemisinins pharmacology
Drug Resistance genetics
Malaria, Falciparum drug therapy
Plasmodium falciparum genetics
Protozoan Proteins genetics
Subjects
Details
- Language :
- English
- ISSN :
- 1474-4457
- Volume :
- 21
- Issue :
- 4
- Database :
- MEDLINE
- Journal :
- The Lancet. Infectious diseases
- Publication Type :
- Academic Journal
- Accession number :
- 33125913
- Full Text :
- https://doi.org/10.1016/S1473-3099(20)30493-X